Post job

NeuroPace main competitors are HeartFlow, Senseonics, and GE Healthcare Holdings Inc.

Competitor Summary. See how NeuroPace compares to its main competitors:

  • Medtronic has the most employees (104,950).
  • Employees at HeartFlow earn more than most of the competitors, with an average yearly salary of $91,504.
  • The oldest company is Medtronic, founded in 1949.
Work at NeuroPace?
Share your experience

NeuroPace vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1997
4.4
Mountain View, CA1$79.9M152
1988
4.5
-4$303.9M1,050
1996
3.7
Lake Forest, CA1$3.2M125
1949
4.7
Minneapolis, MN26$17.0B104,950
2007
4.1
North Andover, MA3$9.9M49
1990
4.2
Bethesda, MD1$12.5M47
2007
4.2
Redwood City, CA2$70.0M302
1996
4.1
Germantown, MD1$22.5M135
2004
4.6
Framingham, MA1$180.0M350
2000
3.8
North Syracuse, NY1$28.3M125
1993
4.1
Boulder, CO1$17.2M279
1989
4.8
Arlington Heights, IL1$18.3B54,000
Guided Therapeutics
1992
3.1
Norcross, GA1$1.0M5
1982
4.3
Manchester, NH1$46.3M200

Rate how well NeuroPace differentiates itself from its competitors.

Zippia waving zebra

NeuroPace salaries vs competitors

Among NeuroPace competitors, employees at HeartFlow earn the most with an average yearly salary of $91,504.

Compare NeuroPace salaries vs competitors

CompanyAverage salaryHourly salarySalary score
NeuroPace
$46,429$22.32-
AngioDynamics
$50,008$24.04-
ReVision Optics
$69,217$33.28-
Medtronic
$73,671$35.42-
Ivenix
$45,715$21.98-
BrainScope Company
$55,975$26.91-

Compare NeuroPace job title salaries vs competitors

CompanyHighest salaryHourly salary
NeuroPace
$32,273$15.52
GE Healthcare Holdings Inc.
$36,547$17.57
HeartWare International
$36,400$17.50
AngioDynamics
$35,228$16.94
BrainScope Company
$34,708$16.69
Medtronic
$33,562$16.14
Hyde Engineering + Consulting
$33,129$15.93
HeartFlow
$32,312$15.53
Jadak Technologies
$32,308$15.53
Ivenix
$32,131$15.45
Guided Therapeutics
$32,118$15.44
Senseonics
$32,117$15.44
ReVision Optics
$32,023$15.40
DEKA Research
$32,009$15.39

Do you work at NeuroPace?

Is NeuroPace able to compete effectively with similar companies?

NeuroPace jobs

NeuroPace demographics vs competitors

Compare gender at NeuroPace vs competitors

Job titleMaleFemale
AngioDynamics47%53%
Medtronic57%43%
GE Healthcare Holdings Inc.64%36%
Senseonics74%26%
HeartFlow83%17%
NeuroPace--
Male
Female

Compare race at NeuroPace vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
61%11%16%8%4%
9.7
33%7%14%36%11%
6.8
57%12%9%18%4%
9.9
55%20%8%13%4%
9.9
35%26%5%30%3%
6.5
34%7%15%35%9%
7.2

NeuroPace and similar companies CEOs

CEOBio
James Christopher Clemmer
AngioDynamics

President and Chief Executive Officer Jim Clemmer joined AngioDynamics in April 2016, bringing more than 25 years of leadership within the healthcare industry and a proven track record of success. Prior to AngioDynamics, Clemmer served as president of the $1.8 billion medical supplies segment at Covidien plc., where he directed strategic and day-to-day operations for global business divisions that collectively manufactured 23 different product categories. In addition, he managed global manufacturing, research and development, operational excellence, business development and all other functions associated with the medical supplies business. Prior to his role at Covidien, Clemmer served as group president at Kendall Healthcare, where he managed the US business across five divisions and built the strategic plan for the Medical Supplies segment before it was spun off from Tyco. Clemmer began his career at Sage Products, Inc. Clemmer currently serves on the Board of Directors for AngioDynamics and Lantheus Medical Imaging. Clemmer is a graduate of the Massachusetts College of Liberal Arts.

Timothy T. Goodnow
Senseonics

Tim Goodnow is the President and Chief Executive Officer at Senseonics, Inc. Tim joined the Senseonics Board of Directors in December 2010 and in March 2011 was named President & CEO. Tim has been instrumental in commercializing the first 90-day Eversense CGM System in Europe and the 180-day product - Eversense XL - which is now distributed in more than 15 countries. He also successfully launched Eversense in the U.S. only 40 days after FDA approval. Tim continues to drive innovation, product development and new technology for future CGM systems. Prior to Senseonics, Tim was Vice President of Technical Operations at Abbott Diabetes Care. He also held executive positions at TheraSense, Verax Biomedical, Dade Behring and Baxter Healthcare. Tim earned his PhD and Bachelor of Science degree in Chemistry at the University of Miami.

Kaylie is a student University of Mississippi graduating in 2021 and is based in Oxford, Mississippi. She is a Student Worker at CIE Ole Miss and Chief Executive Officer at HEARTWARE INTERNATIONAL, INC.. Kaylie attended Southport High School between 2014 and 2018.

Geoffrey Straub Martha
Medtronic

Geoff Martha is firmly establishing Medtronic as the undisputed global leader in healthcare technology. As chairman & CEO, Geoff leads the $30 billion company and its 90,000 employees in pursuit of fulfilling the Medtronic Mission to use technology to improve human welfare. He is recognized as a driven and innovative executive - ranking in Modern Healthcare’s 100 Most Influential People in Healthcare in 2020 and listed as the #1 CEO in healthcare technology by the Healthcare Technology Report in 2021.Geoff became CEO in April 2020. Under his leadership, Medtronic is putting the ‘tech’ in MedTech, leveraging the latest advances in cutting edge technology to transform healthcare. Fortune Magazine named Medtronic among the top 15 companies for its 2020 “Change the World” list, recognizing its swift efforts during the pandemic, and listed the company on its 2021 list of Most Admired Companies.Geoff joined Medtronic in 2011, and notably led the acquisition and integration of Covidien, the largest acquisition in the medical technology industry. Before joining Medtronic, Geoff spent 19 years at GE Healthcare and GE Capital.Geoff is a member of the Business Roundtable, and the World Economic Forum’s International Business Council. He also co-chairs the Taskforce on Health and Life Sciences for B20, a G20 engagement group.An ardent supporter of philanthropic and diversity initiatives, Geoff serves on the board of directors for the Medtronic Foundation, Children’s HeartLink, and the Northside Achievement Zone. He is part of OneTen, a coalition of cross-industry leaders committed to breaking down systemic barriers for Black Americans. He also serves as Medtronic’s Executive Sponsor to FIRST Robotics.Geoff received a bachelor’s degree in Finance from Pennsylvania State University, where he currently serves on the Development Council for its College of Liberal Arts. He was also captain of the Penn State men’s hockey team and later inducted into its Hockey Hall of Fame.

Dean Kamen
DEKA Research

Founder of DEKA research and FIRST Robotics for kids, inventor of the iBot wheelchair and numerous successful products. Helicopter, fixed wing pilot.

Jorgen Bundgaard Hansen
Ivenix

+ 20 year’s experience in leading midsize and large organizations with a proven track record in strategy, sales, marketing, operations and M&A. Lived and worked in EU, USA and Asia.Track record of leading public and private equity owned companies in all major areas of business leadership including CEO, COO, President, division head. Have headed large functional teams including sales, marketing, R&D and operations/supply chain all with an international/global scope.Built high performing teams and promoted organizational diversity, agility and employee well-being, through strategic alignment/deployment, team empowerment, team building, leadership training and coaching.Have led transformational turn-arounds, change management and major restructurings.Transformed US domestic company into scalable global, matrix company.Stewarded +25 M&A deals in US, Europa and APAC.Extensive investor relations experience.Specialty: Leading large organizations with a global agenda of growth and/or major transformational needs.

John Stevens M.D.
HeartFlow

Susan Hertzberg
BrainScope Company

Ms. Hertzberg joined Boston Heart Diagnostics in July, 2010 as President and Chief Executive Officer. She has over 25 years of experience in the diagnostics and healthcare services industry and has played key executive roles in sales, marketing, and operations in both early stage and established diagnostics companies. From 2008 to 2010, Ms. Hertzberg was President and CEO of Ipsogen Inc., a start-up molecular diagnostics company with a portfolio of assays designed to personalize the treatment of blood and breast cancer. Under her leadership, she built a significant US presence, delivered exceptional top-line growth and positioned the company for future acquisition. The Company was purchased by Qiagen Inc. shortly after her departure in early 2011. Ms. Hertzberg’s previous executive experiences were at Abbott Diagnostics where she focused on building a service delivery platform for top tier domestic and international customers and Oxford Health Plans, where she was responsible for all ancillary contracting. Ms. Hertzberg spent much of her career at Quest Diagnostics, progressing through a variety of management and executive positions, including sales, marketing, purchasing and supply chain management. Ms. Hertzberg received an MBA degree from Columbia University and a BA degree in psychology from Clemson University. She serves on the Board of Directors for TheraCare, a private healthcare, rehabilitation, developmental and educational service organization focused on special educational needs.

As President of Hyde Engineering + Consulting, Inc., Kerren Bergman leads a global engineering resources organization of more than 200 employees. Her responsibilities include the strategic direction of the management team, global operations and overseeing the attracting, developing and retention of talent to enhance the growth of Hyde’s diverse and inclusive organization. Kerren began her career with Hyde in 1998, advancing with the company in various roles of increasing responsibility. Her experience in nearly every aspect of the business including Operations, Business Development, Human Resources, Quality, Safety and IT has been exponential in understanding all the moving parts of operational oversight. As a hands-on leader, Kerren guides Hyde by cultivating an ‘attitude of gratitude’. She is driven, collaborative, visionary. and passionate about people, Kerren embodies Hyde’s mission to foster a collaborative culture and exceed client expectations while continuing to invest in the industry’s foremost engineering professionals. She intelligently manages and empowers the organization to embrace the 5 Hyde values; Family, Integrity, Respect, Wisdom, Adventure. Kerren holds a Bachelor of Arts and Master’s in Education from the University of California, Los Angeles (UCLA). She is Past President of the International Society for Pharmaceutical Engineering - Rocky Mountain Chapter (ISPE-RM), as well as a member of the Society for Human Resource Management (SHRM). In her spare time, Kerren enjoys spending time with her two daughters, singing, playing violin and piano, and kickboxing.

NeuroPace competitors FAQs

Search for jobs